Related references
Note: Only part of the references are listed.CHIP-mediated CIB1 ubiquitination regulated epithelial-mesenchymal transition and tumor metastasis in lung adenocarcinoma
Yuanqi Liu et al.
CELL DEATH AND DIFFERENTIATION (2021)
Clinical significance of circPVT1 in patients with non-small cell lung cancer who received cisplatin combined with gemcitabine chemotherapy
Huasong Lu et al.
TUMORI JOURNAL (2021)
DAP3 Is Involved in Modulation of Cellular Radiation Response by RIG-I-Like Receptor Agonist in Human Lung Adenocarcinoma Cells
Yoshiaki Sato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy
Oliver Klein et al.
CANCER CELL (2021)
A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma
Jie Wu et al.
ONCOGENE (2021)
The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non-small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials
Cheng-Qiong Wang et al.
FRONTIERS IN PHARMACOLOGY (2021)
The prognostic role of the Transducin-like Enhancer of split protein family in lung adenocarcinoma
Qianli Ma et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials
A. Galvano et al.
ESMO OPEN (2021)
Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways
Jiaxin Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Predictive value of tumor mutation burden (TMB) with targeted next-generation sequencing in immuno-checkpoint inhibitors for non-small cell lung cancer (NSCLC)
Xiaoting Ma et al.
JOURNAL OF CANCER (2021)
Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development
Semi Lim et al.
NATURE CHEMICAL BIOLOGY (2020)
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Michael A. Gillette et al.
CELL (2020)
Integrative Proteomic Characterization of Human Lung Adenocarcinoma
Jun-Yu Xu et al.
CELL (2020)
USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress
Yueguang Wu et al.
CELL DEATH & DISEASE (2020)
The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor
Lianlian Ouyang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018)
F. Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon et al.
NATURE MEDICINE (2019)
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data (vol 11, 34, 2019)
Francesca Finotello et al.
GENOME MEDICINE (2019)
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China
Xiaohua Gu et al.
LUNG CANCER (2019)
Non-Small Cell Lung Cancer, Version 1.2020 Featured Updates to the NCCN Guidelines
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
iUUCD 2.0: an update with rich annotations for ubiquitin and ubiquitin-like conjugations
Jiaqi Zhou et al.
NUCLEIC ACIDS RESEARCH (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cisplatin/etoposide or paclitaxel/carboplatin with concurrent radiation therapy in stage IIIB non-small cell lung cancer: A one-year phase II trial at a low resource setting
M. Shuayb et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells
Genbao Shao et al.
MOLECULAR CANCER (2018)
Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer
Shang-Gin Wu et al.
MOLECULAR CANCER (2018)
Structure and Function of the 26S Proteasome
Jared A. M. Bard et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 87 (2018)
Deficiency of parkin and PINK1 impairs age-dependent mitophagy in Drosophila
Tom Cornelissen et al.
ELIFE (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Selumetinib for the treatment of non-small cell lung cancer
Francesca Casaluce et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Integrative clinical genomics of metastatic cancer
Dan R. Robinson et al.
NATURE (2017)
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for PatientsWith Stage III Non-Small-Cell Lung Cancer A Systematic Review
Conor E. Steuer et al.
JAMA ONCOLOGY (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial
J. Liang et al.
ANNALS OF ONCOLOGY (2017)
Cell-fate determination by ubiquitin-dependent regulation of translation
Achim Werner et al.
NATURE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
The Roles of Post-translational Modifications in the Context of Protein Interaction Networks
Guangyou Duan et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Mitophagy Enhances Oncolytic Measles Virus Replication by Mitigating DDX58/RIG-I-Like Receptor Signaling
Mao Xia et al.
JOURNAL OF VIROLOGY (2014)
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
Paul Geeleher et al.
GENOME BIOLOGY (2014)
Axitinib for the treatment of advanced non-small-cell lung cancer
Judy W. King et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2013)
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
Vincenzo Valentini et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Ubiquitination of CD86 Is a Key Mechanism in Regulating Antigen Presentation by Dendritic Cells
Guenther Baravalle et al.
JOURNAL OF IMMUNOLOGY (2011)
Grg1 acts as a lung-specific oncogene in a transgenic mouse model
T Allen et al.
CANCER RESEARCH (2006)
Share Paper
